442 related articles for article (PubMed ID: 9414189)
41. Mitotic Index and Progression-Free Survival in Atypical Meningiomas.
Domingo RA; Tripathi S; Vivas-Buitrago T; Lu VM; Chaichana KL; Quiñones-Hinojosa A
World Neurosurg; 2020 Oct; 142():191-196. PubMed ID: 32615290
[TBL] [Abstract][Full Text] [Related]
42. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
Biczok A; Jungk C; Egensperger R; von Deimling A; Suchorska B; Tonn JC; Herold-Mende C; Schichor C
J Neurooncol; 2019 Dec; 145(3):469-477. PubMed ID: 31713016
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
44. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients.
Perry A; Chicoine MR; Filiput E; Miller JP; Cross DT
Cancer; 2001 Aug; 92(3):701-11. PubMed ID: 11505418
[TBL] [Abstract][Full Text] [Related]
46. Meningiomas invading the superior sagittal sinus: surgical experience in 108 cases.
DiMeco F; Li KW; Casali C; Ciceri E; Giombini S; Filippini G; Broggi G; Solero CL
Neurosurgery; 2004 Dec; 55(6):1263-72; discussion 1272-4. PubMed ID: 15574208
[TBL] [Abstract][Full Text] [Related]
47. Surgery for convexity meningiomas.
Morokoff AP; Zauberman J; Black PM
Neurosurgery; 2008 Sep; 63(3):427-33; discussion 433-4. PubMed ID: 18812953
[TBL] [Abstract][Full Text] [Related]
48. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
Hsu DW; Efird JT; Hedley-Whyte ET
J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
[TBL] [Abstract][Full Text] [Related]
49. Recurrence of olfactory groove meningiomas.
Obeid F; Al-Mefty O
Neurosurgery; 2003 Sep; 53(3):534-42; discussion 542-3. PubMed ID: 12943570
[TBL] [Abstract][Full Text] [Related]
50. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma.
Tao X; Wang K; Dong J; Hou Z; Wu Z; Zhang J; Liu B
World Neurosurg; 2017 Oct; 106():152-164. PubMed ID: 28673887
[TBL] [Abstract][Full Text] [Related]
51. Local control and overall survival in atypical meningioma: a retrospective study.
Goyal LK; Suh JH; Mohan DS; Prayson RA; Lee J; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):57-61. PubMed ID: 10656373
[TBL] [Abstract][Full Text] [Related]
52. Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.
Loewenstern J; Shuman W; Rutland JW; Kessler RA; Kohli KM; Umphlett M; Pain M; Bederson J; Fowkes M; Shrivastava RK
World Neurosurg; 2019 Aug; 128():e148-e156. PubMed ID: 30995555
[TBL] [Abstract][Full Text] [Related]
53. Histopathology and prognosis in human meningiomas.
Backer-Grøndahl T; Moen BH; Sundstrøm SH; Torp SH
APMIS; 2014 Sep; 122(9):856-66. PubMed ID: 24698127
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
[TBL] [Abstract][Full Text] [Related]
55. Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.
Chohan MO; Ryan CT; Singh R; Lanning RM; Reiner AS; Rosenblum MK; Tabar V; Gutin PH
Neurosurgery; 2018 Jun; 82(6):824-832. PubMed ID: 28645194
[TBL] [Abstract][Full Text] [Related]
56. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
58. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.
Maier H; Ofner D; Hittmair A; Kitz K; Budka H
J Neurosurg; 1992 Oct; 77(4):616-23. PubMed ID: 1527622
[TBL] [Abstract][Full Text] [Related]
59. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
60. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
